Sanofi and GSK announce that they have signed a letter of intent to develop an adjuvanted vaccine for COVID-19, using innovative technology from both companies, to help address the ongoing pandemic.
The CPhI Pharma portfolio confirms new exhibition dates for CPhI Japan, CPhI South East Asia and CPhI North America. Following a detailed review of attendee requirements and event feasibility...
